| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
44
|
49 |
| HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
23
|
17 |
| CCDC162P |
|
coiled-coil domain containing 162, pseudogene
|
|
|
0.890 |
0.154 |
21
|
28 |
| LINC02210-CRHR1 |
P34998
|
LINC02210-CRHR1 readthrough
|
|
|
0.570 |
0.692 |
20
|
30 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
20
|
24 |
| LIPC-AS1 |
|
LIPC antisense RNA 1
|
|
|
0.839 |
0.154 |
19
|
7 |
| LINC00461 |
|
long intergenic non-protein coding RNA 461
|
|
|
0.736 |
0.423 |
19
|
24 |
| BORCS7-ASMT |
|
BORCS7-ASMT readthrough (NMD candidate)
|
|
|
0.805 |
0.154 |
18
|
15 |
| MEF2C-AS1 |
|
MEF2C antisense RNA 1
|
|
|
0.861 |
0.154 |
17
|
31 |
| CADM3-AS1 |
|
CADM3 antisense RNA 1
|
|
|
1.000 |
0.038 |
14
|
8 |
| MSH5-SAPCD1 |
|
MSH5-SAPCD1 readthrough (NMD candidate)
|
|
|
0.760 |
0.423 |
14
|
10 |
| MIR29B2CHG |
|
MIR29B2 and MIR29C host gene
|
|
|
0.839 |
0.192 |
13
|
12 |
| SLC8A1-AS1 |
|
SLC8A1 antisense RNA 1
|
|
|
0.792 |
0.231 |
13
|
13 |
| ZSCAN16-AS1 |
|
ZSCAN16 antisense RNA 1
|
|
|
0.792 |
0.269 |
13
|
13 |
| LINC01876 |
|
long intergenic non-protein coding RNA 1876
|
|
|
0.861 |
0.115 |
13
|
15 |
| LINC02571 |
|
long intergenic non-protein coding RNA 2571
|
|
|
0.743 |
0.500 |
12
|
12 |
| CMAHP |
Q9Y471
|
cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene
|
|
|
0.805 |
0.346 |
12
|
16 |
| LINC00240 |
|
long intergenic non-protein coding RNA 240
|
|
|
0.821 |
0.231 |
11
|
10 |
| MIR100HG |
|
mir-100-let-7a-2-mir-125b-1 cluster host gene
|
|
|
0.682 |
0.308 |
11
|
11 |
| LINC00243 |
|
long intergenic non-protein coding RNA 243
|
|
|
0.729 |
0.423 |
10
|
10 |
| PROX1-AS1 |
|
PROX1 antisense RNA 1
|
|
|
0.780 |
0.231 |
9
|
8 |
| LINC01470 |
|
long intergenic non-protein coding RNA 1470
|
|
|
0.890 |
0.077 |
9
|
28 |
| RERE-AS1 |
|
RERE antisense RNA 1
|
|
|
0.890 |
0.077 |
9
|
7 |
| SOX2-OT |
|
SOX2 overlapping transcript
|
|
|
0.597 |
0.615 |
9
|
12 |